Table 1 Main clinical characteristics of the 40 enrolled patients.
Patients’ characteristics | N (%) |
|---|---|
Tumor stage | |
Stage I | 9 (22.5%) |
Stage II | 9 (22.5%) |
Stage III | 14 (35.0%) |
Stage IV | 2 (5.0%) |
n.d. | 6 (15.0%) |
Surgical margin status | |
R0 | 21 (52.5%) |
R1 | 13 (32.5%) |
n.d. | 6 (15.0%) |
Lymph node involvement | |
N+ | 9 (22.5%) |
N0 | 24 (60.0%) |
n.d. | 7 (17.5%) |
Systemic treatment | |
Yes | 30 |
No | 10 |
Serum CA 19.9 at diagnosis | |
> 37 U/ml | 17 (42.5%) |
< 37 U/ml | 20 (50.0%) |
n.d. | 3 (7.5%) |
Hepatitis profiles | |
HCV | 3 (7.5%) |
HBV | 2 (5.0%) |
Autoimmune | 2 (5.0%) |
NO hepatitis/other | 33 (82.5%) |
History of alcohol consumption | |
Yes | 8 (20.0%) |
No | 29 (72.5%) |
n.d. | 3 (7.5%) |
Smoke abuse | |
Yes | 23 |
No | 17 |
Diabetes mellitus | |
Yes | 4 (10.0%) |
No | 33 (82.5%) |
n.d. | 3 (7.5%) |
